Overview of Healthcare Landscape in Singapore
Asia-Pacific’s Medical Technology (MedTech) sector is expected to grow from US$88 billion in output in 2015 to US$133 billion by 2020—surpassing the EU to become the world’s second-largest MedTech market. With its government’s push towards becoming a Smart Nation, Singapore is leading the region in MedTech research and development. It is now called home by more than 60 multinational MedTech firms.
This year, the Nordic Innovation House Singapore (NIH-SG) theme on NORDIC HEALTH aims to support and provide Nordic companies an opportunity to expand their foothold in Singapore and Southeast Asia. NIH-SG shares the mission to bridge Nordic Health-related delegations with its core Trade Promotion Offices (TPOs) from Finland, Sweden, Norway, and Iceland.
On Tuesday 15 September (16:30-18:00 SGT), Dr. Marta Bettinazzi - IP Business Advisor of South-East Asia IPR SME Helpdesk and Jonas Lindsay MSci - External Expert of South-East Asia IPR SME Helpdesk & Senior Associate of Marks & Clerk Singapore LLP will deliver a brief presentation focussing on IP matters related to software in digital health sector.